Simple genomes, complex interactions: Epistasis in RNA virus, Chaos: An Interdisciplinary Journal of Nonlinear Science, vol.20, issue.2, p.26106, 2010. ,
DOI : 10.1063/1.3449300
Mendels Principles of Heredity Cambridge, 1909. ,
Epistasis between deleterious mutations and the evolution of recombination, Trends in Ecology & Evolution, vol.22, issue.6, pp.308-315, 2007. ,
DOI : 10.1016/j.tree.2007.02.014
EVOLUTION: Epistasis in RNA Viruses, Science, vol.306, issue.5701, pp.1492-1493, 2004. ,
DOI : 10.1126/science.1106677
Fitness Landscapes and the Origin of Species Princeton University Press, 2004. ,
Epistasis and the release of genetic variation during long-term selection, Nature Genetics, vol.37, issue.4, pp.418-420, 2006. ,
DOI : 10.1038/ng1761
Dissection of epistasis in oligogenic Bardet???Biedl syndrome, Nature, vol.97, issue.7074, pp.326-330, 2006. ,
DOI : 10.1038/nature04370
Detecting gene???gene interactions that underlie human diseases, Nature Reviews Genetics, vol.8, issue.6, pp.392-404, 2009. ,
DOI : 10.1038/nrg2579
Functional epistasis on a common MHC haplotype associated with multiple sclerosis, Nature, vol.4, pp.574-577, 2006. ,
DOI : 10.1038/nature05133
Why have sex? The population genetics of sex and recombination, Biochemical Society Transactions, vol.34, issue.4, pp.519-522, 2006. ,
DOI : 10.1042/BST0340519
The evolution of sex: empirical insights into the roles of epistasis and drift, Nature Reviews Genetics, vol.84, issue.2, pp.139-149, 2007. ,
DOI : 10.1038/nrg1985
PERSPECTIVE: EVOLUTION AND DETECTION OF GENETIC ROBUSTNESS, Evolution, vol.3, issue.9, pp.1959-1972, 2003. ,
DOI : 10.1086/280260
Crystal Structure of an Ancient Protein: Evolution by Conformational Epistasis, Science, vol.317, issue.5844, pp.1544-1548, 2007. ,
DOI : 10.1126/science.1142819
Epistasis and Its Relationship to Canalization in the RNA Virus ??6, Genetics, vol.167, issue.2, pp.559-567, 2004. ,
DOI : 10.1534/genetics.103.021196
Understanding the Evolutionary Fate of Finite Populations: The Dynamics of Mutational Effects, PLoS Biology, vol.152, issue.4, p.94, 2007. ,
DOI : 10.1371/journal.pbio.0050094.sd001
URL : https://hal.archives-ouvertes.fr/inserm-00708255
Little Evidence for Synergism Among Deleterious Mutations in a Nonsegmented RNA Virus, Journal of Molecular Evolution, vol.49, issue.5, pp.703-707, 1999. ,
DOI : 10.1007/PL00000082
RNA virus error catastrophe: Direct molecular test by using ribavirin, Proceedings of the National Academy of Sciences, vol.98, issue.12, pp.6895-6900, 2001. ,
DOI : 10.1073/pnas.111085598
The contribution of epistasis to the architecture of fitness in an RNA virus, Proceedings of the National Academy of Sciences, vol.101, issue.43, pp.15376-15379, 2004. ,
DOI : 10.1073/pnas.0404125101
Epistatic Roles of E2 Glycoprotein Mutations in Adaption of Chikungunya Virus to Aedes Albopictus and Ae. Aegypti Mosquitoes, PLoS ONE, vol.9, issue.8, p.6835, 2009. ,
DOI : 10.1371/journal.pone.0006835.s003
Evidence for Positive Epistasis in HIV-1, Science, vol.306, issue.5701, pp.1547-1550, 2004. ,
DOI : 10.1126/science.1101786
Fitness Epistasis and Constraints on Adaptation in a Human Immunodeficiency Virus Type 1 Protein Region, Genetics, vol.185, issue.1, pp.293-303, 2010. ,
DOI : 10.1534/genetics.109.112458
HIV-1 Protease Catalytic Efficiency Effects Caused by Random Single Amino Acid Substitutions, Molecular Biology and Evolution, vol.24, issue.2, pp.382-387, 2007. ,
DOI : 10.1093/molbev/msl168
Epistasis among Deleterious Mutations in the HIV-1 Protease, Journal of Molecular Biology, vol.392, issue.2, pp.243-250, 2009. ,
DOI : 10.1016/j.jmb.2009.07.015
Effects of Random Mutations in the Human Immunodeficiency Virus Type 1 Transcriptional Promoter on Viral Fitness in Different Host Cell Environments, Journal of Virology, vol.80, issue.13, pp.6678-6685, 2006. ,
DOI : 10.1128/JVI.02547-05
Mechanisms of genetic robustness in RNA viruses, EMBO reports, vol.73, issue.2, pp.168-173, 2006. ,
DOI : 10.1128/JVI.74.20.9546-9552.2000
HIV-1 over time: fitness loss or robustness gain?, Nature Reviews Microbiology, vol.95, issue.9, p.1, 2007. ,
DOI : 10.1038/nrmicro1594-c1
Recombination: Multiply infected spleen cells in HIV patients, Nature, vol.366, issue.6894, p.144, 2002. ,
DOI : 10.1073/pnas.97.26.14566
Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients, J Virol, vol.70, pp.7894-7899, 1996. ,
Comment on "Evidence for Positive Epistasis in HIV-1", Science, vol.312, issue.5775, p.848, 2006. ,
DOI : 10.1126/science.1109904
Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs), Cellular and Molecular Life Sciences, vol.57, issue.10, pp.1408-1422, 2000. ,
DOI : 10.1007/PL00000626
Estimating HIV Evolutionary Pathways and the Genetic Barrier to Drug Resistance, The Journal of Infectious Diseases, vol.191, issue.11, pp.1953-1960, 2005. ,
DOI : 10.1086/430005
Why Do HIV-1 and HIV-2 Use Different Pathways to Develop AZT Resistance?, PLoS Pathogens, vol.276, issue.2, p.10, 2006. ,
DOI : 0021-9258(2001)276[48725:TEODRM]2.0.CO;2
Mutagenic study of codons 74 and 215 of the human immunodeficiency virus type 1 reverse transcriptase, which are significant in nucleoside analog resistance, J Virol, vol.68, pp.3421-3424, 1994. ,
T20-insensitive HIV-1 from na??ve patients exhibits high viral fitness in a novel dual-color competition assay on primary cells, Virology, vol.333, issue.2, pp.251-262, 2005. ,
DOI : 10.1016/j.virol.2004.12.035
Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro, J Virol, vol.72, pp.3773-3778, 1998. ,
Fitness Comparison of Thymidine Analog Resistance Pathways in Human Immunodeficiency Virus Type 1, Journal of Virology, vol.80, issue.14, pp.7020-7027, 2006. ,
DOI : 10.1128/JVI.02747-05
Mechanisms of clinical resistance by HIV-I variants to zidovudine and the paradox of reverse transcriptase sensitivity, Drug Resistance Updates, vol.1, issue.1, pp.21-28, 1998. ,
DOI : 10.1016/S1368-7646(98)80211-2
Gene Mutations Conferring Multi???Dideoxynucleoside Resistance, The Journal of Infectious Diseases, vol.177, issue.5, pp.1207-1213, 1998. ,
DOI : 10.1086/515282
A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1, Antimicrobial Agents and Chemotherapy, vol.44, issue.4, pp.920-928, 2000. ,
DOI : 10.1128/AAC.44.4.920-928.2000
Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture., Proceedings of the National Academy of Sciences, vol.88, issue.24, pp.11241-11245, 1991. ,
DOI : 10.1073/pnas.88.24.11241
Adaptation of HIV-1 Depends on the Host-Cell Environment, PLoS ONE, vol.74, issue.10, p.271, 2007. ,
DOI : 10.1371/journal.pone.0000271.s002
Effects of 39- deoxynucleoside 59-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA, J Virol, vol.70, pp.712-720, 1996. ,
Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription., Antimicrobial Agents and Chemotherapy, vol.38, issue.5, pp.1008-1016, 1994. ,
DOI : 10.1128/AAC.38.5.1008
Virus Dynamics, 2000. ,
Stochastic Interplay between Mutation and Recombination during the Acquisition of Drug Resistance Mutations in Human Immunodeficiency Virus Type 1, Journal of Virology, vol.79, issue.21, pp.13572-13578, 2005. ,
DOI : 10.1128/JVI.79.21.13572-13578.2005
Effect of Varying Epistasis on the Evolution of Recombination, Genetics, vol.173, issue.2, pp.589-597, 2006. ,
DOI : 10.1534/genetics.105.053108
Evolution of Mutational Robustness in an RNA Virus, PLoS Biology, vol.36, issue.11, p.381, 2005. ,
DOI : 10.1371/journal.pbio.0030381.st002
URL : https://hal.archives-ouvertes.fr/inserm-00708445
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency, Nature Medicine, vol.4, issue.12, pp.1284-1290, 1995. ,
DOI : 10.1038/373117a0
Viral complementation allows HIV-1 replication without integration, Retrovirology, vol.5, issue.1, p.60, 2008. ,
DOI : 10.1186/1742-4690-5-60
Is HIV-1 evolving to a less virulent form in humans?, Nature Reviews Microbiology, vol.17, issue.2, pp.141-151, 2007. ,
DOI : 10.1089/aid.2005.21.1060
Site-directed mutagenesis by overlap extension using the polymerase chain reaction, Gene, vol.77, issue.1, pp.51-59, 1989. ,
DOI : 10.1016/0378-1119(89)90358-2
Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5, Journal of General Virology, vol.36, issue.1, pp.59-74, 1977. ,
DOI : 10.1099/0022-1317-36-1-59
Zidovudine triphosphate and lamivudine triphosphate concentration???response relationships in HIV-infected persons, AIDS, vol.14, issue.14, pp.2137-2144, 2000. ,
DOI : 10.1097/00002030-200009290-00010
Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure., Antimicrobial Agents and Chemotherapy, vol.36, issue.11, pp.2473-2477, 1992. ,
DOI : 10.1128/AAC.36.11.2473
Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1, J Virol, vol.72, pp.2855-2864, 1998. ,
Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy, Antimicrobial Agents and Chemotherapy, vol.46, issue.6, pp.1896-1905, 2002. ,
DOI : 10.1128/AAC.46.6.1896-1905.2002
Statistical Methods in Medical Research Blackwell Science Ltd, 2002. ,